| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Seattle Genetics/Astellas |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: Astellas Pharma |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Arcus Biosciences |
| Recipient: You |
| Company: Loxo/Lilly |
| Recipient: You |
| Company: Daiichi Sankyo/Astra Zeneca |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: AVEO |
| Recipient: You |
| Company: Hexagon |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: Exelixis |
| Recipient: Your Institution |
| Company: Calithera Biosciences |
| Recipient: Your Institution |
| Company: Seattle Genetics/Astellas |
| Recipient: Your Institution |
| Company: Pfizer/EMD Serono |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|